IESC vs. RVPH
IESC (IES Holdings, Inc.) and RVPH (Reviva Pharmaceuticals Holdings, Inc.) are both stocks. IESC operates in Engineering & Construction (Industrials), while RVPH operates in Biotechnology (Healthcare). Over the past 5 years, IESC returned 68.75%/yr vs -63.76%/yr for RVPH. Their 0.09 correlation means their historical movements had little consistent relationship.
Performance
IESC vs. RVPH - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IESC achieves a 91.39% return, which is significantly higher than RVPH's -92.15% return.
IESC
- 1D
- 30.27%
- 1M
- 13.84%
- 6M
- 95.78%
- YTD
- 91.39%
- 1Y
- 112.48%
- 3Y*
- 134.42%
- 5Y*
- 68.75%
- 10Y*
- 48.90%
- ALL TIME*
- 14.92%
RVPH
- 1D
- 0.08%
- 1M
- -33.66%
- 6M
- -92.51%
- YTD
- -92.15%
- 1Y
- -94.97%
- 3Y*
- -83.40%
- 5Y*
- -63.76%
- 10Y*
- —
- ALL TIME*
- -54.26%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $133.30M | $144.24M | $175.40M | |
| $28.52K | $31.29K | $163.05K |
IESC vs. RVPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
IESC IES Holdings, Inc. | 91.39% | 93.58% | 153.67% | 122.72% | -29.76% | 9.99% | 79.42% | 65.02% | -13.95% |
RVPH Reviva Pharmaceuticals Holdings, Inc. | -92.15% | -84.59% | -64.85% | 21.18% | 47.06% | -66.95% | -16.40% | 6.19% | 2.07% |
Correlation
The correlation between IESC and RVPH is 0.12, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.12 |
Correlation (3Y) Balances recent behavior with more history. | 0.10 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.11 |
Correlation (All Time) Calculated using the full available price history since Oct 18, 2018 | 0.09 |
Fundamentals
IESC:
$14.83B
RVPH:
$5.74M
IESC:
$27.72
RVPH:
-$4.17M
IESC:
12.23
RVPH:
0.18
IESC:
$3.99B
RVPH:
$0.00
IESC:
$1.03B
RVPH:
$0.00
IESC:
$582.79M
RVPH:
-$20.20T
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IESC vs. RVPH — Risk / Return Rank
IESC
RVPH
IESC vs. RVPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for IES Holdings, Inc. (IESC) and Reviva Pharmaceuticals Holdings, Inc. (RVPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IESC | RVPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.08 | ||
| Sortino ratioReturn per unit of downside risk | +3.32 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 0.84 | +0.44 |
| Calmar ratioReturn relative to maximum drawdown | 3.16 | -0.97 | +4.13 |
| Martin ratioReturn relative to average drawdown | 11.65 | -1.37 | +13.02 |
Loading charts...
Drawdowns
IESC vs. RVPH - Drawdown Comparison
The maximum IESC drawdown since its inception was -98.78%, roughly equal to the maximum RVPH drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for IESC and RVPH.
Loading charts...
Drawdown Indicators
| IESC | RVPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.78% | -99.86% | +1.08% |
Max Drawdown (1Y)Largest decline over 1 year | -35.26% | -98.02% | +62.76% |
Max Drawdown (3Y)Largest decline over 3 years | -49.23% | -99.72% | +50.49% |
Max Drawdown (5Y)Largest decline over 5 years | -54.22% | -99.81% | +45.59% |
Max Drawdown (10Y)Largest decline over 10 years | -54.28% | — | — |
Current DrawdownCurrent decline from peak | -2.87% | -99.82% | +96.95% |
Average DrawdownAverage peak-to-trough decline | -54.78% | -56.36% | +1.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.56% | 69.31% | -59.75% |
Volatility
IESC vs. RVPH - Volatility Comparison
IES Holdings, Inc. (IESC) and Reviva Pharmaceuticals Holdings, Inc. (RVPH) have volatilities of 37.94% and 39.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IESC | RVPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 37.94% | 39.01% | -1.07% |
Volatility (6M)Calculated over the trailing 6-month period | 61.10% | 148.04% | -86.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 73.89% | 167.77% | -93.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 57.05% | 130.94% | -73.89% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.51% | 114.39% | -64.88% |
Dividends
IESC vs. RVPH - Dividend Comparison
Neither IESC nor RVPH has paid dividends to shareholders.
Financials
IESC vs. RVPH - Financials Comparison
This section allows you to compare key financial metrics between IES Holdings, Inc. and Reviva Pharmaceuticals Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IESC and RVPH have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RVPH has higher volatility (39.01%) compared to IESC (37.94%). In terms of maximum drawdown, IESC dropped -98.78% vs RVPH's -99.86%.
IESC currently has the higher Sharpe Ratio (1.51 vs -0.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IESC and RVPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer